Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › BSX

FARALLON CAPITAL MANAGEMENT, L.L.C. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 10,521,184 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$449.0M, representing 2.08% of its reported portfolio and ranking #15 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)10.52M sh
Reported value held$449.04M
Portfolio Weight2.08%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s BSX position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in BSX in Q3 2023 at 5,039,257 shares (US$266.1M). The position peaked in Q4 2025 at 7,439,564 shares, worth US$709.4M. Across 12 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 10,521,184 shares valued at US$449.0M — an increase of 3,050,500 shares quarter over quarter.. Notable position changes include a 32% increase in Q3 2024 (shares rose 7% over the following quarter), a 57% increase in Q4 2025 (shares fell 34% over the following quarter), a 41% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.04M $266.07M New
Q4 2023 5.82M $336.47M Add
Q1 2024 4.60M $314.83M Reduce
Q2 2024 4.11M $316.45M Reduce
Q3 2024 5.43M $454.67M Add
Q4 2024 5.02M $448.65M Reduce
Q1 2025 3.76M $379.59M Reduce
Q2 2025 3.98M $427.61M Add
Q3 2025 4.75M $463.41M Add
Q4 2025 7.44M $709.36M Add
Q1 2026 7.47M $468.79M Hold
Q2 2026 10.52M $449.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held BSX?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in BSX?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 10.52M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $449.04M, representing 2.08% of its reported portfolio and ranking #15.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling BSX?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in BSX. The position peaked in Q4 2025 at 7.44M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.